Series B Funded Startups in Ireland
Series B rounds in Ireland show a wide disclosed range, led by Wayflyer’s $150M round on 2022-02-01, which dwarfs the next-largest disclosed amounts of $80…
Series B rounds in Ireland show a wide disclosed range, led by Wayflyer’s $150M round on 2022-02-01, which dwarfs the next-largest disclosed amounts of $80M (ProVerum Medical, 2025-08-25) and $60M (Fonoa, 2022-07-21). At the low end, several rounds cluster at $4M, including SOMAÍ Pharmaceuticals (2024-04-01), Impedans (2022-07-21), and Ostoform (2021-10-27), with Neuromod Devices at $11M reinforcing a long tail below the $20M–$50M bulk.
Geographically, Dublin dominates the list: 14 of 19 rows list Dublin, while single-city locations include Carlingford (Louth), Cork, Oranmore (Galway), and Galway (Oranmore). Temporally, the page spans 2021-01-20 (Neurent Medical) through 2025-09-17 (Nory AI), and the most recent 2024–2025 period includes multiple Dublin-based biotech and health care deals (e.g., ProVerum Medical $80M on 2025-08-25 and Neuromod Devices $11M on 2025-03-11).
Most recent rounds
19 shownRelated listings
Frequently asked
What is the largest disclosed Series B round in this Ireland list, and how far above the rest is it?
Wayflyer’s disclosed $150M round (2022-02-01) is the only figure in the $100M+ range on the page, and it stands well above the next-largest disclosed amounts: ProVerum Medical at $80M (2025-08-25) and Fonoa at $60M (2022-07-21).
Are there outliers in disclosed size that might skew how analysts interpret the typical round size?
Yes. The low end is repeatedly $4M (SOMAÍ Pharmaceuticals on 2024-04-01, Impedans on 2022-07-21, and Ostoform on 2021-10-27), while the high end is led by Wayflyer at $150M (2022-02-01). This creates both a clear high-size outlier and a repeated low-size cluster.
Which city over-represents Series B rounds here, and what is the geographic spread beyond it?
Dublin is listed on 14 of 19 rows, including ProVerum Medical (2025-08-25, $80M) and Tines (2024-04-24, $50M). Outside Dublin, the list includes Carlingford, Louth (XOCEAN, 2024-06-10, $32M), Cork (Workvivo, 2022-06-28, $22M; Keelvar, 2022-05-16, $24M), and Oranmore, Galway (Neurent Medical, 2021-01-20, $25M).
How concentrated are rounds in the most recent part of the timeline on this page?
The rows extend from 2021-01-20 (Neurent Medical) to 2025-09-17 (Nory AI). Within the most recent 12 months shown, Dublin-based deals include ProVerum Medical at $80M (2025-08-25), Nory AI at $37M (2025-09-17), and Neuromod Devices at $11M (2025-03-11), indicating continued activity rather than a single-date spike.
Do any sectors appear repeatedly enough to suggest a structural cluster in Ireland’s Series B activity?
Health Care appears frequently (e.g., ProVerum Medical $80M on 2025-08-25, Spectrum Life $18M on 2024-05-27, and Neurent Medical $25M on 2021-01-20). Biotechnology also recurs (Neuromod Devices $11M on 2025-03-11; SOMAÍ Pharmaceuticals $4M on 2024-04-01; Impedans $4M on 2022-07-21; Neurent Medical $25M is also listed under Health Care rather than Biotechnology), supporting a health-and-life-sciences tilt across the list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.